CXCR5 expression was significantly associated with patients’ tumor site, clinical stage, involvement of surgical margin, local regional recurrence, distant metastasis and histological subtype (p = 0.038, p = 0.017, p = 0.04, p = 0.008, p = 0.001 and p = 0.008, respectively), but not with age, sex, complaint and tumor size (all p > 0.05) (Table 1). The gene discussed is CXCR5; the disease is neoplasm.